US Patent

US11369567 — Aqueous suspension suitable for oral administration

Formulation · Assigned to Liqmeds Worldwide Ltd · Expires 2037-06-07 · 11y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a liquid oral dosage form of a lipid-lowering agent suitable for oral administration to humans or animals.

USPTO Abstract

The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.

Drugs covered by this patent

Patent Metadata

Patent number
US11369567
Jurisdiction
US
Classification
Formulation
Expires
2037-06-07
Drug substance claim
No
Drug product claim
Yes
Assignee
Liqmeds Worldwide Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.